Documentos relacionados

1. Complement biology for hematologists.
2. Complement and the prothrombotic state.
3. Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system.
4. Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product.
5. [Current treatment of paroxysmal nocturnal hemoglobinuria and prospects for new therapeutic agents in the future].
6. Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria.
7. Molecular pharmacology in complement-mediated hemolytic disorders.
8. Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.
9. Complement in human disease: approved and up-and-coming therapeutics.
10. Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway.